Selected Presentations to: national conferences (National Association Managed Care Physicians, Institute of Health and Productivy Management, Association for Community Cancer Centers (ACCC) Spring and Fall Conferences, First Annual conference for Association for Value0Based Cancer Care, Oncology World Congress, Medical Group Management Association (MGMA), Community Oncology Congress, Association of Managed Care Pharmacists, AOHA Annual Conference (Administrators in Oncology Hematology Assembly – affiliate of the MGMA), Oncology Economics Summit, 4th Annual National Pay for Performance Summit), CBI’s Effective Oncology Benefit Management, CBI’s Sixth Annual Specialty Pharmacy Conference, state conferences for dozens of state oncology associations, and numerous other regional or practice meetings.
§ “Oncology Overview and Issues for Payers”
§ “Oncology Overview for Employers”
§ “Oncology Community Practice: Then and Now, Practice and Pressures”
§ “Oncology Management: Public and Private, Physician, Payer and Third Party”
§ “2011 Oncology Issues and Trends”
§ “2010 – 2011 Oncology Trend Report” – for Genentech
§ “Patient Navigators – Trends and Issues”
§ “Oncology Management Trends: Who, How, Why, and What you need to ask”
§ New Realities of Oncology Contracting for Payers and Physicians”
§ “2010 Oncology Issues and Trends”
§ “Oncology and Specialty Pharmacy: The Issues, Challenges and Future”
§ “2009 Oncology Issues and Trends”
§ “Who’s Managing Oncology: A Growing Question for Payers, Provider (and others)
§ “Comparative Effectiveness and Oncology” – Chaired and Presented in a 4 Hour Workshop
§ “More Stormy Weather Ahead: What to Expect re the OIG Work Plan, RACs and the Red Flag rules”
§ “Oncology and Specialty Pharmacy: trends and issues for Oncology and Payers”
§ Panel Discussion and Moderator “Pursuing quality care in 2008”
§ Panel Discussion and Moderator “Payers and Providers: A love match?”
§ “Proving Value in Oncology: The Visible and Invisible Issues”
§ “Understanding Oncology”
§ “Pay for Performance and Oncology: Opportunities and Issues”
§ “Buy and Bill or Specialty Pharmacy: Who Decides?”
§ “Canadian Drugs – What the Marketing Brochures don’t tell you”
§ “The Evolution of Community Oncology”
§ “What is Community Oncology”
§ “Oncology in the 21st Century: Proving Value”
§ “Pay for Performance, Disease Management and Quality: Survival Skills for Oncology for the Next Two Years”
§ “Oncology Payer Updates – Trends in Quality and Pay for Performance”
§ “Pay for Performance - The Inevitable Future”
§ “Future Strategies of Oncology Management in Specialty Pharmacy”
§ “CMS CAP From Provider Perspective”
§ “Oncology – Is it compatible with Specialty Pharmacy”
§ “Oncology Reimbursement and Legislative Policy Updates”
§ “Optimizing Patient Care and Payer Relationships in a Changing Environment”
§ “The Basics of Marketing for Oncology”
§ “In a New World of Pay for Quality, the Not so Obvious Oncology Marketing Solutions”